ImmunoPrecise Antibodies ... (IPA)
0.44
0.01 (3.04%)
At close: Apr 17, 2025, 3:59 PM
ImmunoPrecise Antibodies Revenue
ImmunoPrecise Antibodies reported an annual revenue of $24.52M, reflecting a 18.65% growth. For the quarter ending January 31, 2025, ImmunoPrecise Antibodies generated $6.15M in revenue.
Revenue (ttm)
$24.52M
Revenue Growth
18.65%
Price / Sales Ratio
1.84
Revenue / Employee
$340.53K
Employees
72
Market Cap
20.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Apr 30, 2024 | 24.52M | +18.65% |
| Apr 30, 2023 | 20.66M | +6.72% |
| Apr 30, 2022 | 19.36M | +8.11% |
| Apr 30, 2021 | 17.91M | +27.42% |
| Apr 30, 2020 | 14.06M | n/a |